Skip to main content
Top
Published in: Gastric Cancer 1/2012

01-09-2012 | Review Article

A systematic review of patient surveillance after curative gastrectomy for gastric cancer: a brief review

Authors: Roberta Cardoso, Natalie G. Coburn, Rajini Seevaratnam, Alyson Mahar, Lucy Helyer, Calvin Law, Simron Singh

Published in: Gastric Cancer | Special Issue 1/2012

Login to get access

Abstract

Background

Complete resection of a gastric cancer and adjacent lymph nodes offers the only chance for cure of the disease. However, disease recurrence occurs in 22–51% of cases, and its prognosis is very poor. Many clinicians perform post-operative follow-up for these patients, although there is no consensus on the regimen, frequency of visits, mode of testing, or the rationale of a follow-up program.

Purpose

The objective of this systematic review was to identify the evidence for surveillance in patients with resected gastric cancer, specifically examining the interval of follow-up and the modalities utilized.

Methods

Electronic literature searches were conducted using Medline, Embase, and the Cochrane Central Register of Controlled Trials from January 1st 1998 to December 1st 2009. All search titles and abstracts were independently rated for relevance by a minimum of two reviewers.

Results

Five articles were selected. A total of 810 patients underwent post-operative follow-up. History and physical examination, hematological and chemistry profile, endoscopy (esophagogastroduodenoscopy [EGD]), and computed tomography (CT) were the most frequently employed modalities. CT detected the majority of recurrences in the included studies. The survival post-recurrence was significantly higher in the asymptomatic group compared with symptomatic group in three studies, but this may simply reflect lead-time bias. No differences in overall survival (OS) were found.

Conclusion

The included studies failed to show an improvement in OS with more intense surveillance. Further prospective studies are required to determine whether a subgroup of patients may benefit from more intensive follow-up.
Appendix
Available only for authorised users
Literature
1.
go back to reference Marrelli D, De Stefano A, de Manzoni G, Morgagni P, Di Leo A, Roviello F. Prediction of recurrence after radical surgery for gastric cancer: a scoring system obtained from a prospective multicenter study. Ann Surg. 2005;241(2):247–55.PubMedCrossRef Marrelli D, De Stefano A, de Manzoni G, Morgagni P, Di Leo A, Roviello F. Prediction of recurrence after radical surgery for gastric cancer: a scoring system obtained from a prospective multicenter study. Ann Surg. 2005;241(2):247–55.PubMedCrossRef
2.
go back to reference Tan IT, So BYJ. Value of intensive follow-up of patients after curative surgery for gastric carcinoma. J Surg Oncol. 2007;96:503–6.PubMedCrossRef Tan IT, So BYJ. Value of intensive follow-up of patients after curative surgery for gastric carcinoma. J Surg Oncol. 2007;96:503–6.PubMedCrossRef
3.
go back to reference Mikani K, Yamashita Y, Maekawa T, Shinohara T, Yamauchi Y, Hoshino S, et al. Surveillance program for recurrence after curative gastric cancer surgery. Chir Gastroenterol. 2007;23:392–8.CrossRef Mikani K, Yamashita Y, Maekawa T, Shinohara T, Yamauchi Y, Hoshino S, et al. Surveillance program for recurrence after curative gastric cancer surgery. Chir Gastroenterol. 2007;23:392–8.CrossRef
4.
go back to reference Jackson C, Cunningham D, Oliveira J, On behalf of the ESMO Guidelines Working Group. Gastric cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol. 2009;20(Supplement 4):iv34–6. Jackson C, Cunningham D, Oliveira J, On behalf of the ESMO Guidelines Working Group. Gastric cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol. 2009;20(Supplement 4):iv34–6.
5.
go back to reference Allum WH, Griffin SM, Watson A, Colin-Jones D. Guidelines for the management of oesophageal and gastric cancer. Gut. 2002;50(Suppl 5):v1–23.PubMedCrossRef Allum WH, Griffin SM, Watson A, Colin-Jones D. Guidelines for the management of oesophageal and gastric cancer. Gut. 2002;50(Suppl 5):v1–23.PubMedCrossRef
6.
go back to reference Bennett JJ, Gonen M, D’Angelica M, Jaques DP, Brennan MF, Coit DG. Is detection of asymptomatic recurrence after curative resection associated with improved survival in patients with gastric cancer? J Am Coll Surg. 2005;201(4):503–510.PubMedCrossRef Bennett JJ, Gonen M, D’Angelica M, Jaques DP, Brennan MF, Coit DG. Is detection of asymptomatic recurrence after curative resection associated with improved survival in patients with gastric cancer? J Am Coll Surg. 2005;201(4):503–510.PubMedCrossRef
7.
go back to reference Bohner H, Zimmer T, Hopfenmuller W, Berger G, Buhr H-J. Detection and prognosis of recurrent gastric cancer—is routine follow-up after gastrectomy worthwhile? Hepatogastroenterology. 2000;47:1489–94.PubMed Bohner H, Zimmer T, Hopfenmuller W, Berger G, Buhr H-J. Detection and prognosis of recurrent gastric cancer—is routine follow-up after gastrectomy worthwhile? Hepatogastroenterology. 2000;47:1489–94.PubMed
8.
go back to reference Kodera Y, Ito S, Yamamura Y, Mochizuki Y, Fujiwara M, Hibi K, et al. Follow-up surveillance for recurrence after curative gastric cancer surgery lacks survival benefit. Ann Surg Oncol. 2003;10(8):898–902.PubMedCrossRef Kodera Y, Ito S, Yamamura Y, Mochizuki Y, Fujiwara M, Hibi K, et al. Follow-up surveillance for recurrence after curative gastric cancer surgery lacks survival benefit. Ann Surg Oncol. 2003;10(8):898–902.PubMedCrossRef
9.
go back to reference Qui MZ, Lin JZ, Wang ZQ, Pan ZZ, Luo HY, Li YH, et al. Cutoff value of carcinoembryonic antigen and carbohydrate antigen 19-9 elevation levels for monitoring recurrence in patients with resectable gastric adenocarcinoma. Int J Biol Markers. 2009;24(4):258–64. Qui MZ, Lin JZ, Wang ZQ, Pan ZZ, Luo HY, Li YH, et al. Cutoff value of carcinoembryonic antigen and carbohydrate antigen 19-9 elevation levels for monitoring recurrence in patients with resectable gastric adenocarcinoma. Int J Biol Markers. 2009;24(4):258–64.
10.
go back to reference Bang YJ, Cutsem EV, Feyereislova A, Chung HC, Shen L, Sawaki A, et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet. 2010;376(9741):687–97.PubMedCrossRef Bang YJ, Cutsem EV, Feyereislova A, Chung HC, Shen L, Sawaki A, et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet. 2010;376(9741):687–97.PubMedCrossRef
11.
go back to reference Wattchow DA, Weller DP, Esterman A, Pilotto LS, McGorm K, Hammett Z. General practice vs surgical-based follow-up for patients with colon cancer: randomised controlled trial. Br J Cancer. 2006;94:1116–21.PubMedCrossRef Wattchow DA, Weller DP, Esterman A, Pilotto LS, McGorm K, Hammett Z. General practice vs surgical-based follow-up for patients with colon cancer: randomised controlled trial. Br J Cancer. 2006;94:1116–21.PubMedCrossRef
12.
go back to reference Stiggelbout AM, de Haes JC, Vree R, van de Velde CJ, Bruijninckx CM, van Groningen K. Follow-up of colorectal cancer patients: quality of life and attitudes towards follow-up. Br J Cancer. 1997;75(6):914–20.PubMedCrossRef Stiggelbout AM, de Haes JC, Vree R, van de Velde CJ, Bruijninckx CM, van Groningen K. Follow-up of colorectal cancer patients: quality of life and attitudes towards follow-up. Br J Cancer. 1997;75(6):914–20.PubMedCrossRef
Metadata
Title
A systematic review of patient surveillance after curative gastrectomy for gastric cancer: a brief review
Authors
Roberta Cardoso
Natalie G. Coburn
Rajini Seevaratnam
Alyson Mahar
Lucy Helyer
Calvin Law
Simron Singh
Publication date
01-09-2012
Publisher
Springer Japan
Published in
Gastric Cancer / Issue Special Issue 1/2012
Print ISSN: 1436-3291
Electronic ISSN: 1436-3305
DOI
https://doi.org/10.1007/s10120-012-0142-9

Other articles of this Special Issue 1/2012

Gastric Cancer 1/2012 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.